(redirected from suppressor cells)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.

CELL. A small room in a prison. See Dungeon.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
References in periodicals archive ?
Ostrand-Rosenberg, "Myeloid-derived suppressor cells down-regulate L-selectin expression on [CD4.sup.+] and [CD8.sup.+] T cells," The Journal of Immunology, vol.
Baccega et al., "Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis," PLoS ONE, vol.
Huber et al., "Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine," Journal of Clinical Oncology, vol.
Knudsen et al., "Increased level of both CD4+ FOXP3+ regulatory t cells and CD14+HLA-DR-/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma," Scandinavian Journal of Immunology, vol.
Michaud et al., "CCL2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function," Cell Reports, vol.
DuBois, "CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis," Cancer Cell, vol.
Gilvary et al., "Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin," Scientific Reports, vol.
A subset of myeloid derived suppressor cells (CD38+ MDSCs), CD38+ regulatory T cells (Tregs) and CD38+ B cells (Bregs) were decreased by daratumumab.
The patent includes claims that cover compositions of the immunologically active enantiomer of the cationic lipid R-1,2-dioleoyl-3-trimethyl-ammonium-propane or its racemic mixture with Granulocyte-macrophage colony-stimulating factor to reduce the population of myeloid derived suppressor cells within the tumor microenvironment.
Caprion said plans to leverage the proprietary expertise of Serametrix in the analysis of myeloid-derived suppressor cells, as well as its international operations in the US, UK, Australia and China to expand its global geographic coverage.
Myeloid-derived suppressor cells (MDSCs) are immune cells known to play a critical role in impairing anti-viral T-cell responses.